Recombinant PDCD1 (Pembrolizumab Biosimilar) antibody (Biotin)

Catalog No. ABIN7766341

The Humanized Monoclonal anti-PDCD1 (Pembrolizumab Biosimilar) antibody has been validated for FACS, ELISA and CyTox. It is suitable to detect PDCD1 (Pembrolizumab Biosimilar) in samples from Human.

Quick Overview for Recombinant PDCD1 (Pembrolizumab Biosimilar) antibody (Biotin) (ABIN7766341)

Target: PDCD1 (Pembrolizumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Monoclonal

Conjugate: This PDCD1 (Pembrolizumab Biosimilar) antibody is conjugated to Biotin

Application: Flow Cytometry (FACS), ELISA, Cytotoxicity Test (CyTox)

Product Details anti-PDCD1 (Pembrolizumab Biosimilar) Antibody (Biotin)

Purpose: Conjugated Anti-PD-1 (pembrolizumab biosimilar) mAb

Purification: Purified from cell culture supernatant by affinity chromatography

Application Details

Application Notes: working with enzyme-conjugated streptavidin, most applications: 1: 50 - 1: 1,000

Restrictions: For Research Use only

Handling

Buffer: Liquid in PBS, 0.5 % BSA, 40 % Glycerol, 0.02 % Sodium Azide.

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handling Advice: Protect from light!

Storage: 4 °C

Storage Comment: Store at 4°C in dark for 6 months

Target Details for PDCD1 (Pembrolizumab Biosimilar)

Target: PDCD1 (Pembrolizumab Biosimilar)

Alternative Name: pembrolizumab biosimilar

Target Type: Biosimilar

Background: PDCD1, PD1, CD279, SLEB2